查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1788278

全球肺癌筛检软体市场

Lung Cancer Screening Software
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 98 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球肺癌筛检软体市场规模将达 4,050 万美元

2024 年全球肺癌筛检软体市场规模估计为 2,840 万美元，预计到 2030 年将达到 4,050 万美元，在 2024-2030 年分析期内的复合年增长率为 6.1%。

美国市场规模估计为 750 万美元，中国市场预计复合年增长率为 6.0%

美国肺癌筛检软体市场规模预计在2024年达到750万美元。作为世界第二大经济体，中国预计到2030年市场规模将达到650万美元，在2024-2030年的分析期间内，复合年增长率为6.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为5.7%和5.2%。在欧洲，预计德国市场的复合年增长率为4.9%。

全球肺癌筛检软体市场－彻底改变早期检测与诊断

是什么让肺癌筛检软体如此受欢迎？

肺癌是全球癌症相关死亡的主要原因之一，发现较晚会导致高死亡率。早期诊断可显着提高存活率，而肺癌筛检软体成为提高检测准确性和效率的关键工具。人工智慧 (AI) 和机器学习 (ML) 在医学影像领域的应用正在推动市场发展，因为它可以帮助放射科医生和肿瘤科医生更准确地识别肺结节。政府针对长期吸烟者等高风险族群的措施和筛检计画进一步推动了对先进筛检解决方案的需求。肺癌筛检软体正越来越多地被整合到医院放射科和远端医疗平台中，使早期检测更加便捷有效。

创新如何推动肺癌筛检软体的效能？

人工智慧演算法与深度学习模型的整合显着提高了肺癌筛检软体的准确性。这些技术能够检测出微小结节，从而增强影像分析能力，减少诊断中的假阳性和假阴性。云端基础的筛检平台和远端医疗整合正在扩大筛检服务的覆盖范围，尤其是在偏远和服务不足的地区。预测分析的应用正在帮助医生评估患者风险因素，并优先考虑高风险病例进行进一步评估。此外，将肺癌筛检软体与电子健康记录(EHR) 结合，可简化工作流程，提高效率，实现即时数据分析和自动报告。

市场驱动因素有哪些？

推动肺癌筛检软体市场成长的因素有很多。肺癌盛行率的上升和对早期检测的日益重视是关键驱动因素。政府法规和医疗政策对肺癌筛检计画的支持，尤其是在已开发国家，正在加速其普及率。人工智慧和自动化在医疗保健领域的应用日益广泛，以及对数位医疗技术的投资不断增加，进一步推动了对复杂筛检解决方案的需求。此外，云端基础医学影像处理平台的扩展以及软体开发人员和医疗保健提供者之间日益加强的合作，也促进了市场的发展。

面临哪些挑战和未来机会？

儘管肺癌筛检软体市场潜力巨大，但它仍面临着许多挑战，例如高昂的实施成本、资料隐私问题以及与现有医疗IT系统的互通性问题。依赖手动影像分析的传统放射科医生的抵制也可能减缓其应用。然而，人工智慧辅助诊断的日益普及、更具成本效益的云端基础解决方案的开发以及法规合规性的进步，正在创造巨大的机会。未来市场的成长将由人工智慧支援的即时诊断、基于基因和生活方式因素的个人化筛检通讯协定以及肺癌筛检软体与行动医疗应用的整合所驱动。

部分

单段

受访公司范例

  • C the Signs
  • Canon Medical Systems Corporation
  • Dxcover Ltd
  • Eon
  • FUJIFILM Holdings Corporation
  • Guardant Health
  • iDNA
  • ITK-SNAP
  • Koninklijke Philips NV
  • MagView
  • Medtronic
  • MRS Systems, Inc.
  • Nuance Communications, Inc.
  • Oatmeal Health
  • Optellum
  • PenRad Technologies, Inc.
  • Siemens Healthineers AG
  • Thynk Health
  • Volpara Health
  • VoxelCloud

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有查询通用的 LLM 或特定产业的SLM，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP31929

Global Lung Cancer Screening Software Market to Reach US$40.5 Million by 2030

The global market for Lung Cancer Screening Software estimated at US$28.4 Million in the year 2024, is expected to reach US$40.5 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030.

The U.S. Market is Estimated at US$7.5 Million While China is Forecast to Grow at 6.0% CAGR

The Lung Cancer Screening Software market in the U.S. is estimated at US$7.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Million by the year 2030 trailing a CAGR of 6.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Lung Cancer Screening Software Market - Revolutionizing Early Detection and Diagnosis

Why Is Lung Cancer Screening Software Gaining Popularity?

Lung cancer is one of the leading causes of cancer-related deaths worldwide, with a high mortality rate due to late-stage detection. Early diagnosis significantly improves survival rates, and lung cancer screening software is emerging as a crucial tool in enhancing detection accuracy and efficiency. The adoption of artificial intelligence (AI) and machine learning (ML) in medical imaging is driving the market, as these technologies help radiologists and oncologists identify lung nodules with greater precision. Government initiatives and screening programs aimed at high-risk populations, such as long-term smokers, are further propelling the demand for advanced screening solutions. The increasing integration of lung cancer screening software into hospital radiology departments and telemedicine platforms is making early detection more accessible and effective.

How Are Innovations Enhancing the Performance of Lung Cancer Screening Software?

The integration of AI-driven algorithms and deep learning models is significantly improving the accuracy of lung cancer screening software. These technologies enhance image analysis by detecting even the smallest nodules, reducing false positives and false negatives in diagnosis. Cloud-based screening platforms and telemedicine integration are expanding access to screening services, particularly in remote and underserved areas. The adoption of predictive analytics is helping physicians assess patient risk factors and prioritize high-risk cases for further evaluation. Additionally, the combination of lung cancer screening software with electronic health records (EHRs) is streamlining workflow efficiency, allowing for real-time data analysis and automated reporting.

What Are the Key Market Drivers?

Several factors are fueling the growth of the lung cancer screening software market. The rising prevalence of lung cancer and the increasing emphasis on early detection are key drivers. Government regulations and healthcare policies supporting lung cancer screening programs, particularly in developed nations, are accelerating adoption rates. The growing use of AI and automation in healthcare, along with increasing investments in digital health technologies, is further boosting the demand for sophisticated screening solutions. Additionally, the expansion of cloud-based medical imaging platforms and the increasing collaboration between software developers and healthcare providers are contributing to market growth.

What Challenges and Future Opportunities Exist?

Despite its potential, the lung cancer screening software market faces challenges such as high implementation costs, data privacy concerns, and interoperability issues with existing healthcare IT systems. Resistance from traditional radiologists who rely on manual image analysis may also slow down adoption. However, the growing acceptance of AI-assisted diagnostics, the development of more cost-effective cloud-based solutions, and advancements in regulatory compliance are creating significant opportunities. Future growth in the market will be driven by AI-powered real-time diagnosis, personalized screening protocols based on genetic and lifestyle factors, and the integration of lung cancer screening software into mobile health applications.

SCOPE OF STUDY:

The report analyzes the Lung Cancer Screening Software market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Single Segment

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • C the Signs
  • Canon Medical Systems Corporation
  • Dxcover Ltd
  • Eon
  • FUJIFILM Holdings Corporation
  • Guardant Health
  • iDNA
  • ITK-SNAP
  • Koninklijke Philips N.V.
  • MagView
  • Medtronic
  • MRS Systems, Inc.
  • Nuance Communications, Inc.
  • Oatmeal Health
  • Optellum
  • PenRad Technologies, Inc.
  • Siemens Healthineers AG
  • Thynk Health
  • Volpara Health
  • VoxelCloud

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Lung Cancer Screening Software - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Lung Cancer Incidence Rates Throws the Spotlight on Early Detection and Screening Solutions
    • Growing Emphasis on Precision Medicine Propels Demand for AI-Driven Lung Cancer Screening Software
    • Increasing Government-Led Screening Programs Expands Addressable Market Opportunity for Lung Cancer Detection Tools
    • Escalating Awareness Campaigns on Smoking Risks Drives Adoption of Preventive Screening Technologies
    • Advancements in AI and Deep Learning Algorithms Strengthen the Business Case for Automated Lung Nodule Detection
    • Integration of Lung Cancer Screening Software into Radiology Workflows Accelerates Demand Among Hospitals and Imaging Centers
    • Cloud-Based Diagnostic Platforms Sustain Growth in Remote Screening and Teleradiology Markets
    • Reimbursement Reforms and Coverage Expansion in Developed Markets Drive Commercial Adoption
    • Surge in Geriatric Population at High Risk of Lung Cancer Spurs Demand for Preventive Screening Tools
    • Rapid Uptake of Low-Dose CT (LDCT) in Routine Clinical Practice Fuels Growth of Compatible Screening Software
    • Expansion of National Screening Guidelines Across Key Markets Boosts Software Deployment
    • Enhanced Image Processing Capabilities and 3D Visualization Drives Market Penetration in Oncology Imaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Lung Cancer Screening Software Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Lung Cancer Screening Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Lung Cancer Screening Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • JAPAN
    • Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • CHINA
    • Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • EUROPE
    • Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Lung Cancer Screening Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: Europe 15-Year Perspective for Lung Cancer Screening Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • GERMANY
    • Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • UNITED KINGDOM
    • Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • REST OF EUROPE
    • TABLE 24: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Rest of Europe Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • ASIA-PACIFIC
    • Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 26: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Asia-Pacific Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • REST OF WORLD
    • TABLE 28: Rest of World Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Rest of World Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR

IV. COMPETITION